Jean T. Barbey, MD; Steven Soignet, MD
Disclaimer: Both authors are paid consultants to Cell Therapeutics, Inc., the manufacturer of arsenic trioxide, and have participated in trials evaluating arsenic.
Barbey JT, Soignet S. Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia. Ann Intern Med. ;135:842. doi: 10.7326/0003-4819-135-9-200111060-00021
Download citation file:
Published: Ann Intern Med. 2001;135(9):842.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use